Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20071775 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
Conditions: Lung Cancer;   Breast Cancer;   Prostate Cancer;   Tumors (Others)
Intervention: Biological: MVA-brachyury- TRICOM

Indicates status has not been verified in more than two years